• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON GMBH PREMICATH; LONG-TERM INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON GMBH PREMICATH; LONG-TERM INTRAVASCULAR CATHETER Back to Search Results
Model Number 1261.306
Device Problems Break (1069); Fracture (1260); Material Fragmentation (1261)
Patient Problem No Information (3190)
Event Date 06/30/2020
Event Type  Injury  
Manufacturer Narrative
The malfunctioning device will be returned to vygon for evaluation and investigation.The results of this investigation will be sent to fda in a follow-up mdr with in thirty days of its conclusion.
 
Event Description
When withdrawing the catheter after 10 days it snapped and approximately 6 cm were still inside the patient and surgically have to be removed.
 
Manufacturer Narrative
The complaint is not confirmed.We received the involved sample in 2 parts: first, the catheter fragment, which had ruptured proximal the 6 cm marking and had to be surgically removed, and the proximal catheter part, with an extension line and connected to a 5 ml syringe.The catheter tube had been extremely elongated.A microscopic examination showed the typical breaking edges for excessive tensile stress and the resulting tear.The distal catheter section of the fragment showed severe fibrin formation and the distal tip was half-closed (blood coagulation, fibrin).The catheter had been in place for 10 days.Probably a layer of fibrin had formed on the catheter and then allowed it to adhere to the vein wall.It is known from the technical literature that a calcified fibrin coating can form on the catheter after just 24 hours of exposure, which, if it grows together with the vein wall, can prevent or even make it impossible to remove the catheter.In addition, when removing with forceps, care must be taken to ensure that the forceps are atraumatic.In the instructions for use we have two corresponding notes - the last one could rather lead to a fibrin formation and thus to an adhesion in the vessel."caution: do not over stretch the catheter as it may rupture, causing a catheter embolism." "before handling the product, we recommend that powdered gloves should be washed to remove all residue of starch or glove powder" in case of recurrence we recommend trying the "splint traction method".There were no abnormalities when checking the batch documentations.A leak and flow test is performed on each catheter prior to packaging.A tensile strength test is carried out on a random basis as an in-process test.In addition,100% visual inspections are performed twice and a seal seam inspection.An incoming goods inspection is carried out for all components.This is the second complaint regarding the possibly involved batches 160119gn, 140619gn and 131219gn.And this is the 19th complaint regarding a snapped catheter tube for code 1261.306 within the last three years.The general complaint rate for code 1261.306 in the years 2015 to 2018 is 3,75 %.No further corrective action initiated by quality management as there are no indications for a manufacturing fault.
 
Event Description
When withdrawing the catheter after 10 days it snapped and approximately 6 cm were still inside the patient and surgically have to be removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PREMICATH
Type of Device
LONG-TERM INTRAVASCULAR CATHETER
Manufacturer (Section D)
VYGON GMBH
prager ring 100
aachen 52070
GM  52070
MDR Report Key10239013
MDR Text Key197747827
Report Number2245270-2020-00053
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
PMA/PMN Number
K041468
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number1261.306
Device Lot Number131219GN,140619GN OR 160119GN
Was Device Available for Evaluation? Yes
Date Manufacturer Received06/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-